Packages starting from
Need help in choosing the right package for your medical trip?
Your Health data is protected with us
Tuberculosis (TB) treatment is a structured, multi-drug regimen designed to eliminate Mycobacterium tuberculosis, the bacterium responsible for TB. This airborne infectious disease primarily affects the lungs but can also impact other organs. TB treatment requires strict adherence to medication over a prolonged period—typically 6 to 9 months—to prevent relapse or the development of drug-resistant TB strains.
There are two main types of TB that determine the treatment approach:
Latent TB Infection (LTBI): The person is infected but not contagious and does not show symptoms. Preventive treatment is used to stop progression to active TB.
Active TB Disease: The person is symptomatic and contagious. Requires an intensive drug regimen to treat and prevent transmission.
4.0
91% Rated Value for Money
Complete eradication of TB bacteria from the body
Prevention of transmission to others
Reduced risk of complications like lung damage
Lower chance of developing drug-resistant TB
Improved quality of life and life expectancy
Decrease in TB-related healthcare burden
99%
Success Rate
17+
Tuberculosis Treatment Surgeons
1+
Tuberculosis Treatment
53+
Hospitals Around the world
6+
Lives touched
Tuberculosis (TB) treatment is a structured, multi-drug regimen designed to eliminate Mycobacterium tuberculosis, the bacterium responsible for TB. This airborne infectious disease primarily affects the lungs but can also impact other organs. TB treatment requires strict adherence to medication over a prolonged period—typically 6 to 9 months—to prevent relapse or the development of drug-resistant TB strains.
There are two main types of TB that determine the treatment approach:
Latent TB Infection (LTBI): The person is infected but not contagious and does not show symptoms. Preventive treatment is used to stop progression to active TB.
Active TB Disease: The person is symptomatic and contagious. Requires an intensive drug regimen to treat and prevent transmission.
Persistent cough lasting more than 3 weeks
Coughing up blood or sputum
Chest pain, especially during breathing or coughing
Unexplained weight loss
Fever and night sweats
Fatigue and weakness
Inhalation of airborne TB bacteria from an infected person
Weakened immune system (e.g., HIV/AIDS, diabetes, malnutrition)
Living in or traveling to high TB prevalence areas
Close contact with someone with active TB
Living in crowded or poorly ventilated conditions
Previous incomplete or improper TB treatment
1. Diagnosis:
Chest X-ray, sputum test, and TB skin or blood test (e.g., IGRA).
2. Classification:
Determine if the patient has latent or active TB.
3. Drug Regimen Initiation:
Intensive Phase (First 2 months): Isoniazid, Rifampin, Pyrazinamide, and Ethambutol.
Continuation Phase (4–7 months): Isoniazid and Rifampin.
4. Monitoring and Compliance:
Monthly follow-ups, sputum cultures, liver function tests.
DOT may be implemented to ensure medication adherence.
5. Completion and Assessment:
Confirm treatment success through clinical and microbiological recovery.
Reinforce education on TB prevention and lifestyle.